Hydroctin Dosage

Did you have any side effects with this medicine?

Dosage of Hydroctin in details

infoThe dose of a drug and dosage of the drug are two different terminologies. Dose is defined as the quantity or amount of medicine given by the doctor or taken by the patient at a given period. Dosage is the regimen prescribed by the doctor about how many days and how many times per day the drug is to be taken in specified dose by the patient. The dose is expressed in mg for tablets or gm, micro gm sometimes, ml for syrups or drops for kids syrups. The dose is not fixed for a drug for all conditions, and it changes according to the condition or a disease. It also changes on the age of the patient.

Hydroctin may be administered by IV injection, IV infusion or IM injection. The preferred method for initial emergency use is IV injection.

Following the initial emergency period, consideration should be given to employing a longer-acting injectable preparation or an oral preparation.

Therapy is initiated by administering Hydroctin IV over a period of 30 sec (eg, Hydroctin sodium succinate equivalent to Hydroctin 100 mg) to 10 min (≥500 mg). In general, high-dose corticosteroid therapy should be continued only until the patient's condition has stabilized, usually not beyond 48-72 hrs. Although adverse effects associated with high-dose, short-term corticoid therapy are uncommon, peptic ulceration may occur. Prophylactic antacid therapy may be indicated.

When high-dose Hydroctin therapy must be continued beyond 48-72 hrs, hypernatremia may occur. Under such circumstances, it may be desirable to replace Hydroctin sodium succinate with a corticoid product eg, one containing methylprednisolone sodium succinate which causes little or no sodium retention.

Initial Dose: 100-500 mg or more (Hydroctin equivalent of Hydroctin sodium succinate), depending on the severity of the condition.

This dose may be repeated at intervals of 2, 4 or 6 hrs as indicated by the patient's responses and clinical condition. While the dose may be reduced for infants and children, it is governed more by the severity of the condition and response of the patient than by age or body weight but should not be less than 25 mg daily. Patients subjected to severe stress following corticosteroid therapy should be observed closely for signs and symptoms of adrenocortical insufficiency.

Corticosteroid therapy is an adjunct to, and not a replacement for, conventional therapy.

In Patients with Liver Disease, there may be an increased effect and reduced dosing may be considered.

Administration: Preparation of Solutions:

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

100 mg Plain or with Bacteriostatic Water for Injection: For IV or IM injection, prepare solution by aseptically adding not >2 mL of bacteriostatic water for injection or bacteriostatic sodium chloride injection to the contents of 1 vial. For IV infusion, first prepare solution by adding not >2 mL of bacteriostatic water for injection to the vial; this solution may then be added to 100-1000 mL of the following: dextrose in water 5% (or isotonic saline solution or dextrose in isotonic saline solution 5% if patient is not on sodium restriction).

Directions for Using the Act-O-Vial Two-Compartment Vial: Remove protective cap, give the plunger-stopper a quarter-turn and press to force diluent into the lower compartment.

Gently agitate to effect solution.

Sterilize top of plunger-stopper with a suitable germicide.

Insert needle squarely through center of plunger-stopper until tip is just visible. Invert vial and withdraw dose.

Further dilution is not necessary for IV or IM injection. For IV infusion, first prepare solution as just described. The 100-mg solution may then be added to 100-1,000 mL of dextrose in water 5% (or isotonic saline solution or dextrose in isotonic saline solution 5% if patient is not on sodium restriction). The 250-mg solution may be added to 250-1,000 mL, the 500-mg solution may be added to 500-1,000 mL and the 1,000 mg solution to 1000 mL of the same diluents. In cases where administration of a small volume of fluid is desirable, Hydroctin 100-3,000 mg (Hydroctin equivalent of Hydroctin sodium succinate) may be added to 50 mL of the above diluents. The resulting solutions are stable for at least 4 hrs and may be administered either directly or by IV piggyback.

What other drugs will affect Hydroctin?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Tell your doctor about all your current medicines. Many drugs can affect Hydroctin, especially:

  • birth control pills or hormone replacement therapy;

  • heart medication;

  • insulin or oral diabetes medicine;

  • medicine to prevent organ transplant rejection;

  • medicine to treat an infection;

  • seizure medication;

  • a blood thinner such as warfarin (Coumadin, Jantoven); or

  • aspirin or an NSAID (nonsteroidal anti-inflammatory drug) such as ibuprofen, naproxen, celecoxib, indomethacin, Advil, Aleve, Motrin, and others.

This list is not complete and many other drugs may affect Hydroctin. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Drug Interactions (in more detail)

Hydroctin interactions

infoInteractions are the effects that happen when the drug is taken along with the food or when taken with other medications. Suppose if you are taking a drug Hydroctin, it may have interactions with specific foods and specific medications. It will not interact with all foods and medications. The interactions vary from drug to drug. You need to be aware of interactions of the medicine you take. Most medications may interact with alcohol, tobacco, so be cautious.

With simultaneous use of Hydroctin increases the toxicity of cardiac glycosides (because of the emerging hypokalemia increases the risk of arrhythmias); with acetylsalicylic acid - accelerates its excretion and reduces its concentration in blood plasma (with the abolition of Hydroctin concentration of salicylates in the blood increases, and increases the risk of side effects); with paracetamol - increased risk of hepatotoxic action of paracetamol (induction of hepatic enzymes and formation of a toxic metabolite of paracetamol); with cyclosporine - increased side effects of Hydroctin as a result of inhibition of its metabolism; with ketoconazole - increased side effects of Hydroctin as a result of reduction of its clearance.

Hydroctin Micronised Xepa-Soul Pattinson reduces the effectiveness of hypoglycemic; intensifies the effect of indirect anticoagulants of coumarin derivatives.

Hydroctin reduces the effect of vitamin D on the absorption of calcium ions into the lumen of the intestine. Ergocalciferol and parathyroid hormone hinder the development of osteopathy caused by GCS.

Hydroctin Micronised Xepa-Soul Pattinson increases the metabolism of isoniazid, meksiletina (especially in "fast acetylators"), which leads to a decrease in their plasma concentrations; increases (with prolonged therapy) the content of folic acid reduces the concentration of praziquantel in blood.

Hydroctin in high doses reduces the effect somatropina.

Hypokalemia caused by GCS, may increase the severity and duration of muscle blockade on the background of muscle relaxants.

Antacids reduce the absorption of the GCS.

At simultaneous application with SCS thiazides, carbonic anhydrase inhibitors, other GCS, amphotericin B increase the risk of hypokalemia, drugs containing sodium ions - swelling and increase blood pressure.

NSAIDs and ethanol increases the risk of gastrointestinal ulcerations and bleeding, in combination with NSAIDs to treat arthritis may reduce the dose of GCS due to summation of therapeutic effect. Indomethacin displacing the SCS from its association with albumin, increases the risk of its side effects.

Amphotericin B and carbonic anhydrase inhibitors increase the risk of osteoporosis.

The therapeutic effect of GCS is reduced under the influence of inducers of microsomal liver enzymes (including phenytoin, barbiturates, ephedrine, theophylline, rifampin) due to increased rate of metabolism of these substances.

Inhibitors of the function of the adrenal cortex (including mitotan) may necessitate higher doses of GCS.

Clearance GCS increased against the background of preparations of thyroid hormones.

Immunosuppressants increase the risk of infection and lymphoma or other lymphoproliferative disorders associated with Epstein-Barr virus.

Estrogens (including oral contraceptives containing estrogen) reduce the clearance of GKS, lengthens T1/2 and their therapeutic and toxic effects. The appearance of hirsutism and acne promotes the simultaneous use of other steroid hormone funds - androgens, estrogens, anabolic steroids, oral contraceptives.

Tricyclic antidepressants may increase the severity of depression caused by GCS (not shown for the treatment of these side effects).

The risk of developing cataracts increases with the application against other GCS antipsychotic funds (neuroleptics), carbutamide and azathioprine. Simultaneous of Hydroctin Micronised Xepa-Soul Pattinson with the appointment of m-cholinoblockers, as well as with means having m-anticholinergic action (including antihistamines, tricyclic antidepressants), with nitrates improves the intraocular pressure.

With simultaneous application of SCS with live vaccines and antiviral compared to other types of immunization increases the risk of activation of viruses and development of infections.



  1. DailyMed. "CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. FDA/SPL Indexing Data. "WI4X0X7BPJ: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
  3. MeSH. "Anti-Inflammatory Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).


The results of a survey conducted on ndrugs.com for Hydroctin are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Hydroctin. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported frequency of use

No survey data has been collected yet

Consumer reported doses

No survey data has been collected yet

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name: 
Spam protection:  < Type 20 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2019 ndrugs.com All Rights Reserved